Trial Profile
A Study Comparing Linezolid Versus Daptomycin In The Treatment Of Vancomycin-Resistant Enterococcal Bloodstream Infection (VRE-BSI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Daptomycin
- Indications Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- 27 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016.